发明授权
- 专利标题: Stable formulation of modified GLP-1
- 专利标题(中): 改良GLP-1的稳定配方
-
申请号: US12785861申请日: 2010-05-24
-
公开(公告)号: US08846618B2公开(公告)日: 2014-09-30
- 发明人: James M. Flink , Silke Møller Larsen , Simon Bjerregaard Jensen , Dorthe Kot Engelund
- 申请人: James M. Flink , Silke Møller Larsen , Simon Bjerregaard Jensen , Dorthe Kot Engelund
- 申请人地址: DK Bagsvaerd
- 专利权人: Novo Nordisk A/S
- 当前专利权人: Novo Nordisk A/S
- 当前专利权人地址: DK Bagsvaerd
- 代理商 Rosemarie R. Wilk-Orescan
- 优先权: DK200101010 20010628; DK200101011 20010628; DK200101052 20010704; DK200101053 20010704; DK200200093 20020118
- 主分类号: A61K38/26
- IPC分类号: A61K38/26 ; A61P3/10 ; A61P7/12 ; C07K14/605
摘要:
Pharmaceutical formulations of GLP-1 compounds and methods for preparation thereof.
公开/授权文献
- US20100234299A1 STABLE FORMULATION OF MODIFIED GLP-1 公开/授权日:2010-09-16
信息查询
IPC分类: